Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 428 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Acute Kidney Insufficiency Clear all

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Abbott RDx Cardiometabolic; Other
Eligibility: 21 Years and older
Enrollment: 1,001 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 25
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 21 more

Conditions: Sarcoidosis, Hypercalcemia Due to Sarcoidosis
Interventions: ACTHAR Gel (adrenocorticotropic hormone); Drug
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Albany, New York

Conditions: Burns, Hemofiltration, Kidney Failure, Acute, Shock, Septic
Interventions: An FDA approved continuous renal replacement device, Control Group; Device · Other
Lead sponsor: American Burn Association; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 9
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Tampa, Florida + 6 more

Conditions: Acute Kidney Injury
Interventions: Blood sample; Procedure
Lead sponsor: Avera McKennan Hospital & University Health Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Acute Kidney Injury, Obesity, Proteinuria
Interventions: Urine Sample; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1,434 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Contrast Induced Acute Kidney Injury
Interventions: Isuzinaxib (APX-115), Placebo; Drug
Lead sponsor: Aptabio Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Acute Renal Failure
Interventions: Thymoglobulin, Thymoglobulin 0.75mg/kg dose; Drug
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome
Interventions: Infusion of 200% maintenance fluids as balanced crystalloid IV solution, Oral fluids; infusion of up to 110% maintenance fluids as balanced crystalloid IV solution; Other
Lead sponsor: University of Calgary; Other
Eligibility: 9 Months to 21 Years
Enrollment: 1,040 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 22
States / cities: Birmingham, Alabama • Little Rock, Arkansas • La Jolla, California + 19 more

Conditions: Renal Disease, End-Stage, Renal Insufficiency, Chronic, Renal Insufficiency, Acute
Interventions: Bosutinib; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 5
States / cities: DeLand, Florida • Gainesville, Florida • Miami, Florida + 2 more

Conditions: Acute Kidney Injury, Acute Kidney Injury (AKI)
Interventions: AKI Discharge Summary Template, Chat-Based Educational Messaging Program; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Glen Oaks, New York • Manhasset, New York

Conditions: Acute Kidney Injury
Interventions: Digoxin Antibodies Fab Fragments, Placebo, Baseline EO > 360 pM, EO < 360 pM; Drug · Other · Diagnostic Test
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: SARS-CoV-2 Infection, Acute Kidney Injury
Interventions: Placebo, Nicotinamide riboside; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 4
States / cities: New York, New York • San Antonio, Texas • Seattle, Washington

Conditions: Hydronephrosis, Ultrasound, Acute Kidney Injury
Interventions: Hand-carried ultrasound; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: AKI
Interventions: Nicotinamide Riboside + Pterostilbene, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Kidney Injury, Cirrhosis, Portal Hypertension, Hepatorenal Syndrome, Acute Tubule Necrosis, Prerenal Failure
Interventions: MAP-Target Algorithm; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acute Kidney Injury, Heart; Dysfunction Postoperative, Cardiac Surgery, Children
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 1 Day to 4 Years
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Acute Kidney Injury, Renal Insufficiency, Renal Failure, Pharmacokinetics
Interventions: Levetiracetam, Lacosamide, Phenytoin, Phenobarbital, Ketamine, Valproic Acid; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 80 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Renal Failure
Interventions: alpha-melanocyte stimulating hormone; Drug
Lead sponsor: University of Texas; Other
Eligibility: 18 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2003
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Covid19, Stage 1 Acute Kidney Injury
Interventions: MIB-626, Placebo, Home Treatment; Drug · Other
Lead sponsor: Metro International Biotech, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COVID-19, Acute Kidney Injury, Sepsis
Interventions: SBI-101; Biological
Lead sponsor: Sentien Biotechnologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Albuquerque, New Mexico • Charleston, South Carolina

Conditions: Acute Kidney Injury, Kidney Injury
Interventions: Clarity RMS Electronic Sensor; Device
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Acute Kidney Injury
Interventions: Serial ultrasound assessments for GDT, Usual care; Diagnostic Test
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 16 Years and older
Enrollment: 415 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: COVID-19
Interventions: Azeliragon, Placebo; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Chicago, Illinois • Ann Arbor, Michigan • Galveston, Texas

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Astute Medical, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 6
States / cities: La Mesa, California • Honolulu, Hawaii • Idaho Falls, Idaho + 3 more

Search by objective public record fields.

Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU

ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study

Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)

Pharmacokinetics of Vancomycin in the ICU in Renal Replacement Therapy

Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery?

Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI

Low Dose Thymoglobin in Renal Transplant Patients

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Bosutinib In Subjects With Renal Impairment

COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)

Preop Digifab in CABG to Reduce Ouabain Levels and Prevent AKI

Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection

Hand-carried Ultrasound to Assess Hydronephrosis

Protection From Acute Kidney Injury (AKI) With Basis™ Treatment

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients

Near Infrared Spectroscopy for the Detection of Acute Kidney Injury in Children Following Cardiac Surgery

Pharmacokinetics of Antiepileptics in Patients on CRRT

Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure

Phase 2a MIB-626 vs. Placebo COVID-19

A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy

Automated urIne Flow Detection to Reduce Errors and Nursing Workload

Guidance of Ultrasound in Intensive Care to Direct Euvolemia

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia

Specimen Stability Study